Tyrosine Kinase Inhibitors Serine-Threonine Kinase Inhibitors PI3 Kinase Inhibitors Other Chemokine CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy Epigenetics Cyclin Dependent Kinase Inhibitors | Squamous Cell Carcinoma of Head and Neck | HER2 Positive Breast Cancer | Chordoma | Lung Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Gastric Cancer |
---|---|---|---|---|---|---|---|
everolimus | |||||||
alpelisib + tipifarnib | |||||||
PF-05212384 + trastuzumab-pkrb | |||||||
alpelisib | |||||||
LX-086 | |||||||
tipifarnib | |||||||
GDC-0032 | |||||||
palbociclib + alpelisib | |||||||
nivolumab | |||||||
GDC-0941 | |||||||
EZH2 inhibitor | |||||||
PI3K inhibitor + EZH2 inhibitor |